This review aims to summarize the clinical presentation, management, and guidelines/regulations related to common infectious diseases seen in contact sport athletes. It focuses primarily on infections in wrestlers because skin and soft tissue infections are common in wrestlers and because the infectious issues encountered in wrestling are generalizable to other contact sports and can serve as a model for thinking about these problems in other types of athletes. Also, the burden of disease is much higher in wrestling than in other sports, with 20% of wresters losing practice or competition time due to cutaneous infections each year.^[@bibr4-1941738118789954],[@bibr104-1941738118789954]^

The National Collegiate Athletic Association (NCAA) and National Federation of High School Associations (NFHS) have guidelines for the treatment of many common skin infections before an athlete is allowed to return to wrestling ([Table 1](#table1-1941738118789954){ref-type="table"}).^[@bibr79-1941738118789954],[@bibr80-1941738118789954]^ Previously, the NCAA has published these guidelines in the yearly NCAA Sports Medicine Handbook, but they are now updated intermittently on the NCAA Sport Science Institute website. The NFHS guidelines are recommendations to high school sport associations. Regional and state associations may or may not choose to adopt these guidelines or may make their own. Clinicians should be aware of their local state and regional rules and regulations. Furthermore, treatment of infections in contact sport athletes must often be individualized to address specific issues of treatment duration, timing in the competitive season, local resistance patterns, and athlete factors such as desire for prophylaxis, allergies, and potential side effects of medications. Preferred treatment regimens are listed in [Table 2](#table2-1941738118789954){ref-type="table"}, but there are other effective alternative treatment approaches.

###### 

Guidelines for participation with infectious skin lesions in wrestlers^[@bibr79-1941738118789954],[@bibr80-1941738118789954]^

![](10.1177_1941738118789954-table1)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Condition                                                      NCAA                                                                               NFHS
  -------------------------------------------------------------- ---------------------------------------------------------------------------------- -------------------------------------------------------------------------
  Bacterial infections                                           • No new lesions for 48 hours\                                                     • No new lesions for 48 hours\
                                                                 • 72+ hours of antibiotic therapy\                                                 • 72+ hours of antibiotic therapy\
                                                                 • No moist, exudative, or draining lesions\                                        • No moist, exudative, or draining lesions
                                                                 • May not cover active infections to allow participation\                          
                                                                 • May gram stain questionable lesions                                              

  Primary herpes infection (includes zoster and gladiatorum)     • Must have firm, adherent crust at time of participation\                         • All lesions scabbed over\
                                                                 • No evidence of secondary bacterial infection\                                    • No new lesions for 48+ hours\
                                                                 • No new blisters for 72+ hours\                                                   • 10+ days of antiviral therapy for cutaneous lesions only\
                                                                 • 120+ hours of antiviral therapy\                                                 • 14+ days of antiviral therapy if systemic symptoms
                                                                 • No systemic symptoms\                                                            
                                                                 • May not cover active infections to allow participation                           

  Secondary herpes infection (includes zoster and gladiatorum)   • Must have firm, adherent crust at time of participation\                         • All lesions scabbed over\
                                                                 • No evidence of secondary bacterial infection\                                    • No new lesions for 48+ hours\
                                                                 • No new blisters for 72+ hours\                                                   • 120+ hours of antiviral therapy
                                                                 • 120+ hours of antiviral therapy\                                                 
                                                                 • May not cover active infections to allow participation                           

  Tinea                                                          • Oral or topical treatment for 72+ hours on skin and 14 days on scalp\            • Oral or topical treatment for 72+ hours on skin and 14+ days on scalp
                                                                 • May cover active infections to allow participation                               

  Molluscum                                                      • Curette and cover                                                                • Curette and cover

  Verrucae                                                       • Curette and/or cover\                                                            • Cover if prone to bleeding
                                                                 • Multiple lesions on the face that cannot be covered result in disqualification   

  Hidradenitis suppurativa                                       • Disqualified if extensive drainage\                                              
                                                                 • May not cover active lesions to allow participation                              

  Pediculosis                                                    • Must be completely treated before wrestling\                                     • 24+ hours after treatment
                                                                 • No evidence of active infestation                                                

  Scabies                                                        • Negative scabies prep at time of competition                                     • 24+ hours after treatment

  Conjunctivitis                                                                                                                                    • 24+ hours after treatment
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

NCAA, National Collegiate Athletic Association; NFHS, National Federation of High School Associations.

###### 

Preferred treatment regimens for common infections in contact sport athletes

![](10.1177_1941738118789954-table2)

  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------
  Skin and soft tissue infection^[@bibr1-1941738118789954],[@bibr45-1941738118789954],[@bibr61-1941738118789954],[@bibr65-1941738118789954],[@bibr83-1941738118789954],[@bibr87-1941738118789954],[@bibr92-1941738118789954],[@bibr104-1941738118789954],[@bibr106-1941738118789954]^                                                                                                                                          

   Impetigo                                                                                                                                                                                                                                                                                                                                                                                                                    Clindamycin 400 mg PO 3× daily for 7-14 days or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Cephalexin 250 mg PO 4× daily for 7-14 days or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Dicloxacillin 250 mg PO 4× daily for 7-14 days\
                                                                                                                                                                                                                                                                                                                                                                                                                               plus\
                                                                                                                                                                                                                                                                                                                                                                                                                               Mupirocin 2% ointment 3× daily

   Nonpurulent MSSA infections (erysipelas,  cellulitis, folliculitis, etc)                                                                                                                                                                                                                                                                                                                                                    Cephalexin 250 mg PO 4× daily for 7-14 days or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Dicloxacillin 250 mg PO 4× daily for 7-14 days

   Purulent MSSA infections (furuncle,  carbuncle, abscess, etc)                                                                                                                                                                                                                                                                                                                                                               Incision and drainage\
                                                                                                                                                                                                                                                                                                                                                                                                                               plus (unless well encapsulated with no surrounding erythema and warmth)\
                                                                                                                                                                                                                                                                                                                                                                                                                               Cephalexin 250 mg PO 4× daily for 7-14 days or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Dicloxacillin 250 mg PO 4× daily for 7-14 days

   Nonpurulent MRSA infections                                                                                                                                                                                                                                                                                                                                                                                                 Trimethoprim-sulfamethoxazole DS (160 mg/800 mg); 2 tablets PO 2× daily for 7-14 days or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Clindamycin 400 mg PO 3× daily for 7-14 days or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Linezolid 600 mg PO 2× daily (for trimethoprim-sulfamethoxazole-- and clindamycin-resistant organisms) for 7-14 days\
                                                                                                                                                                                                                                                                                                                                                                                                                               plus\
                                                                                                                                                                                                                                                                                                                                                                                                                               Mupirocin 2% ointment 3× daily

   Purulent MRSA infections                                                                                                                                                                                                                                                                                                                                                                                                    Incision and drainage\
                                                                                                                                                                                                                                                                                                                                                                                                                               plus\
                                                                                                                                                                                                                                                                                                                                                                                                                               Trimethoprim-sulfamethoxazole DS (160 mg/800 mg); 2 tablets PO 2× daily for 7-14 days or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Clindamycin 400 mg PO 3× daily for 7-14 days or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Linezolid 600 mg PO 2× daily (for trimethoprim-sulfamethoxazole-- and clindamycin-resistant organisms) for 7-14 days\
                                                                                                                                                                                                                                                                                                                                                                                                                               plus\
                                                                                                                                                                                                                                                                                                                                                                                                                               Mupirocin 2% ointment 3× daily

  Herpes gladiatorum^[@bibr6-1941738118789954],[@bibr8-1941738118789954][@bibr9-1941738118789954]-[@bibr10-1941738118789954],[@bibr34-1941738118789954],[@bibr40-1941738118789954],[@bibr55-1941738118789954],[@bibr67-1941738118789954],[@bibr104-1941738118789954],[@bibr106-1941738118789954]^                                                                                                                              

   Primary infection                                                                                                                                                                                                                                                                                                                                                                                                           Valacyclovir 1 g PO 2× daily for 10-14 days

   Recurrent infection                                                                                                                                                                                                                                                                                                                                                                                                         Valacyclovir 1 g PO 2× daily for 5-7 days

   Prophylaxis                                                                                                                                                                                                                                                                                                                                                                                                                 Valacyclovir 500 mg PO daily if most recent infection \>2 years ago\
                                                                                                                                                                                                                                                                                                                                                                                                                               Valacyclovir 1 g PO daily if most recent infection \<2 years ago

  Varicella zoster^[@bibr23-1941738118789954],[@bibr49-1941738118789954]^                                                                                                                                                                                                                                                                                                                                                      

   Treatment                                                                                                                                                                                                                                                                                                                                                                                                                   Valacyclovir 1 g 3× daily for 7 days or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Acyclovir 800 mg PO 5× daily for 7 days

   Prophylaxis                                                                                                                                                                                                                                                                                                                                                                                                                 Ensure vaccination or history of VZV infection

  Tinea^[@bibr1-1941738118789954],[@bibr2-1941738118789954],[@bibr11-1941738118789954],[@bibr18-1941738118789954],[@bibr28-1941738118789954],[@bibr48-1941738118789954],[@bibr50-1941738118789954],[@bibr62-1941738118789954][@bibr63-1941738118789954]-[@bibr64-1941738118789954],[@bibr67-1941738118789954],[@bibr86-1941738118789954],[@bibr104-1941738118789954][@bibr105-1941738118789954]-[@bibr106-1941738118789954]^   

   Tinea capitis, barbae, or diffuse/severe tinea  corporis                                                                                                                                                                                                                                                                                                                                                                    Terbinafine 250 mg PO daily for 2-4 weeks or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Itraconazole 200 mg PO daily for 3-4 weeks or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Ketoconazole 200 mg PO daily for 2-4 weeks\
                                                                                                                                                                                                                                                                                                                                                                                                                               plus\
                                                                                                                                                                                                                                                                                                                                                                                                                               Ketoconazole 2% shampoo daily (for tinea capitis only)\
                                                                                                                                                                                                                                                                                                                                                                                                                               *Children:*\
                                                                                                                                                                                                                                                                                                                                                                                                                               Griseofulvin 20 mg/kg daily for 8 weeks or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Terbinafine for 6 weeks (dosing varies by weight)\
                                                                                                                                                                                                                                                                                                                                                                                                                               • \<25 kg: 125 mg PO daily\
                                                                                                                                                                                                                                                                                                                                                                                                                               • 25-35 kg: 187.5 mg PO daily\
                                                                                                                                                                                                                                                                                                                                                                                                                               • \>35 kg: 250 mg PO daily

   Tinea corporis (including adjuvant treatment  of severe tinea corporis)                                                                                                                                                                                                                                                                                                                                                     Any of the following creams applied to the lesion and at least 2 cm surrounding the lesion 2x daily:\
                                                                                                                                                                                                                                                                                                                                                                                                                               • Terbinafine cream\
                                                                                                                                                                                                                                                                                                                                                                                                                               • Clotrimazole cream\
                                                                                                                                                                                                                                                                                                                                                                                                                               • Miconazole cream\
                                                                                                                                                                                                                                                                                                                                                                                                                               • Ketoconazole cream

   Prophylaxis                                                                                                                                                                                                                                                                                                                                                                                                                 Fluconazole 100 mg PO 1× weekly or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Fluconazole 100 mg daily for 3 days at start of season and then again in 6 weeks or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Itraconazole 400 mg 1x every other week or\
                                                                                                                                                                                                                                                                                                                                                                                                                               Terbinafine 250 mg PO 1× weekly (anecdotal)

  Molluscum contagiosum^[@bibr101-1941738118789954],[@bibr104-1941738118789954]^                                                                                                                                                                                                                                                                                                                                               Curettage

  Verrucae^[@bibr33-1941738118789954],[@bibr104-1941738118789954]^                                                                                                                                                                                                                                                                                                                                                             Curettage

  Pediculosis^[@bibr32-1941738118789954],[@bibr41-1941738118789954],[@bibr56-1941738118789954],[@bibr104-1941738118789954]^                                                                                                                                                                                                                                                                                                    Permethrin 1% shampoo once\
                                                                                                                                                                                                                                                                                                                                                                                                                               Repeat 3-7 days later if lice persist

  Scabies^[@bibr96-1941738118789954],[@bibr104-1941738118789954]^                                                                                                                                                                                                                                                                                                                                                              Permetherin 5% cream once

  Conjunctivitis^[@bibr54-1941738118789954],[@bibr80-1941738118789954]^                                                                                                                                                                                                                                                                                                                                                        Polymyxin B/trimethoprim ophthalmic 1 drop both eyes 6× daily for 7-10 days

  Influenza^[@bibr23-1941738118789954]^                                                                                                                                                                                                                                                                                                                                                                                        

   Treatment                                                                                                                                                                                                                                                                                                                                                                                                                   Oseltamivir 75 mg 2× daily for 5 days

   Prophylaxis                                                                                                                                                                                                                                                                                                                                                                                                                 Seasonal influenza vaccine\
                                                                                                                                                                                                                                                                                                                                                                                                                               Oseltamivir 75 mg daily for 10 days after close contact with influenza-infected person

  Mumps prophylaxis^[@bibr21-1941738118789954],[@bibr23-1941738118789954]^                                                                                                                                                                                                                                                                                                                                                     Ensure adequate vaccination\
                                                                                                                                                                                                                                                                                                                                                                                                                               Consider third dose of MMR vaccine in the setting of mumps outbreak

  Other vaccine-preventable illnesses^[@bibr23-1941738118789954]^                                                                                                                                                                                                                                                                                                                                                              Strongly encourage compliance with the recommended CDC vaccination schedule
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------

CDC, Centers for Disease Control and Prevention; DS, double strength; MMR, measles, mumps, rubella; MRSA, methicillin-resistant *Staphylococcus aureus*; MSSA, methicillin-susceptible *Staphylococcus aureus*; PO, per os (by mouth); VZV, varicella zoster virus.

Bacterial Skin Infections {#section7-1941738118789954}
=========================

*Staphylococcus* and *Streptococcus* species infections are among the most common skin and soft tissue infections in humans. Clinical syndromes caused by these bacterial skin infections include impetigo, erysipelas, cellulitis, folliculitis, furuncles, carbuncles, and abscesses. Impetigo, a superficial bacterial infection of the skin that results in blisters, open lesions, and/or honey-colored crusting, is by far the most common. While most of these infections are easily treated with oral and/or topical antibiotics, the rise of community-acquired methicillin-resistant *Staphylococcus aureus* (CA-MRSA) has made empiric treatment of bacterial skin infections more complicated in recent decades.^[@bibr20-1941738118789954],[@bibr69-1941738118789954],[@bibr75-1941738118789954],[@bibr76-1941738118789954]^ No specific signs or symptoms can be used to distinguish CA-MRSA from methicillin-sensitive *Staphylococcus aureus*.^[@bibr17-1941738118789954],[@bibr74-1941738118789954]^

In 2016, it was reported that 0.6% of high school football players and 0.9% of high school wrestlers contract a CA-MRSA infection each season.^[@bibr16-1941738118789954]^ As many as 76% of college wrestlers are carriers of CA-MRSA, which is much higher than seen in other sports.^[@bibr26-1941738118789954]^ Athletes colonized with CA-MRSA are 7 times more likely to suffer a bacterial skin infection than those who are not colonized.^[@bibr58-1941738118789954]^ Recurrent CA-MRSA infections are also common. Although this has not been studied rigorously in athletes, 51% of nonathletes who suffer a CA-MRSA skin infection had a second CA-MRSA infection within 6 months of their initial presentation.^[@bibr77-1941738118789954]^ The major source of these infections in athletes seems to be direct contact with colonized or infected athletes.^[@bibr57-1941738118789954],[@bibr89-1941738118789954]^

It is common for high schools, colleges, and clubs to use antistaphylococcal cleaning supplies and devices to limit CA-MRSA exposure, but there is little evidence that these procedures affect rates of CA-MRSA skin infections. However, there is some evidence that having a written policy outlining procedures for equipment cleaning and identification and early treatment of skin infections might limit CA-MRSA skin infections.^[@bibr43-1941738118789954],[@bibr90-1941738118789954]^

Decolonization of individuals with multiple CA-MRSA infections, or in the setting of a CA-MRSA outbreak, remains controversial. When decolonization is undertaken, the combination of chlorhexidine washes plus 2% mupirocin ointment is preferred. There is limited evidence that mupirocin-based decolonization, without body washes or systemic antibiotics, may decrease the prevalence of skin infections in other populations.^[@bibr78-1941738118789954]^ However, the practice has not been rigorously studied in athletes, and the overall evidence for the utility of this practice is limited.^[@bibr5-1941738118789954],[@bibr17-1941738118789954],[@bibr38-1941738118789954],[@bibr68-1941738118789954],[@bibr70-1941738118789954],[@bibr102-1941738118789954]^ However, it may be reasonable to attempt decolonization in the setting of a CA-MRSA outbreak.^[@bibr44-1941738118789954],[@bibr80-1941738118789954]^

Empiric treatment of bacterial skin infections in athletes should include both topical and systemic treatment tailored to local resistance patterns. For most contact sport athletes, trimethoprim-sulfamethoxazole or clindamycin combined with topical mupirocin is an effective initial treatment regimen. Whenever possible, skin infections should be cultured so that antibiotic sensitivity--directed treatment regimens can be used.^[@bibr17-1941738118789954],[@bibr95-1941738118789954]^ Purulent bacterial skin infections should be treated with incision and drainage.^[@bibr44-1941738118789954],[@bibr74-1941738118789954]^ For localized purulent skin infections, antibiotic therapy may not be necessary after adequate incision and drainage.^[@bibr17-1941738118789954],[@bibr44-1941738118789954],[@bibr74-1941738118789954]^ Severe infections with diffuse skin involvement or systemic symptoms should be treated with intravenous antibiotics, typically in the hospital setting.^[@bibr17-1941738118789954],[@bibr44-1941738118789954],[@bibr104-1941738118789954]^ A summary of treatment recommendations for bacterial skin infections is provided in [Table 2](#table2-1941738118789954){ref-type="table"}.

Herpes Gladiatorum {#section8-1941738118789954}
==================

Herpes simplex virus (HSV) types I and 2 are common infectious agents in humans. Originally termed *herpes gladiatorum* (HG) by Selling and Kibrick in 1964, the term HG became widely used after a report in 1989 when a 28-day wrestling camp had 60 wrestlers out of 175 who contracted the virus, forcing the Public Health Department to close the camp.^[@bibr14-1941738118789954]^ Similar outbreaks in 1999 and 2001 also caused the camp to shut down. In 2007, the Minnesota State High School League mandated an 8-day hiatus in wrestling activities when 24 wrestlers, across multiple teams, developed HG. By the end of the quarantine, 56 wrestlers had been diagnosed. Several other outbreaks have been documented in recent years, most notably 2014 in Arizona and 2016 in California. It has been suggested that 20% to 40% of collegiate wrestlers will suffer an outbreak of HG each year.^[@bibr4-1941738118789954],[@bibr55-1941738118789954],[@bibr104-1941738118789954]^

In wrestling, 94% to 97% of HSV infections are caused by type 1 infection.^[@bibr7-1941738118789954],[@bibr14-1941738118789954],[@bibr35-1941738118789954],[@bibr55-1941738118789954],[@bibr83-1941738118789954],[@bibr86-1941738118789954],[@bibr99-1941738118789954],[@bibr104-1941738118789954]^ Transmission is almost exclusively from direct skin-to-skin contact. Multiple studies have indicated that training mats and other fomites do not significantly contribute to the spread of infection.^[@bibr7-1941738118789954],[@bibr10-1941738118789954],[@bibr55-1941738118789954],[@bibr83-1941738118789954]^ A total of 29% to 30% of high school wrestlers are infected or colonized with HSV, but only 3% are aware they carry the virus.^[@bibr8-1941738118789954]^ This discrepancy is the primary reason that large outbreaks seem to occur for unknown reasons and leads to the lack of proper suspicion when such outbreaks do develop. When health care providers encounter a wrestler with HG, the diagnosis is often missed. One study determined that the correct diagnosis was made at initial presentation in less than 10% of cases.^[@bibr35-1941738118789954]^ When outbreaks occur, the popular media tend to focus on issues of hygiene or sanitation rather than the ubiquity and ease of transmission of the virus. There is extensive education from the NCAA, NFHS, and USA Wrestling about prevention, recognition, and treatment of herpes.^[@bibr79-1941738118789954],[@bibr80-1941738118789954]^ Furthermore, within the same community, nonwrestlers and wrestlers have the same rates of HSV seropositivity. In fact, females from the same school and age group are more likely to be seropositive for HSV than male wrestlers.^[@bibr91-1941738118789954]^

The face is involved in more than 70% of herpes outbreaks in wrestling.^[@bibr7-1941738118789954]^ Infection of the fingers or thumb (herpetic whitlow) and of other commonly abraded areas of the body account for most of the remaining 30%.^[@bibr7-1941738118789954]^ Underlying skin conditions, such as eczema, can increase the risk of HSV skin infection. Occasionally, ocular involvement can occur. Herpes keratitis (corneal involvement) can lead to scarring and, with repeated outbreaks, may result in permanent clouding of the cornea, requiring corneal transplantation to preserve proper vision. Rarely, but more seriously, retinal necrosis can occur and lead to blindness.^[@bibr52-1941738118789954],[@bibr99-1941738118789954]^ Herpes-induced retinal necrosis is the most common source of blindness from an infectious source in the United States.^[@bibr6-1941738118789954],[@bibr99-1941738118789954]^

In wrestling, the conspiring problems of misdiagnosis and inconvenient timing can lead to postseason confusion and controversy. Infections contracted during regional or sectional competition typically become symptomatic 8 to 10 days later, just prior to the start of state championship competitions. This can result in athletes being withheld from the most important competition of their season. The Centers for Disease Control and Prevention's report on the 2014 Arizona outbreak concluded that "lack of proper suspicion and culturing" probably accounted for overdiagnosis of bacterial infections and underdiagnosis of HG.^[@bibr103-1941738118789954]^

Primary HG outbreaks typically present with systemic symptoms, including malaise, low-grade fever, sore throat, and swollen/tender anterior and posterior cervical adenopathy.^[@bibr83-1941738118789954],[@bibr106-1941738118789954]^ One to 2 days later, 1- to 2-mm-diameter diffuse patches of 3 to 10 vesicles will coalesce with a minimally reddened base ([Figure 1](#fig1-1941738118789954){ref-type="fig"}). The majority (90%-93%) of infections will occur within 8 days of exposure.^[@bibr7-1941738118789954]^ The virus is transmitted via viral replication in ganglia and spread along sensory nerve tissue. Multiple dermatomes and both sides of the face, head, and neck may be involved. Occasionally this may extend to the upper extremities as well.^[@bibr7-1941738118789954],[@bibr55-1941738118789954],[@bibr83-1941738118789954],[@bibr106-1941738118789954]^ Distribution of lesions commonly reflects the wrestler's dominant hand, and lesions are more likely to occur on the side of the head of the wrestler's preferred tie position.^[@bibr7-1941738118789954],[@bibr55-1941738118789954],[@bibr106-1941738118789954]^

![Primary herpes gladiatorum. Note multiple areas of involvement and regional adenopathy.](10.1177_1941738118789954-fig1){#fig1-1941738118789954}

Recurrent HG typically involves fewer vesicles, and outbreaks are shorter in duration. Reactivation of dormant virus in ganglia leads to new outbreaks that occur, and will reoccur, in the same dermatomal or peripheral nerve pattern ([Figure 2](#fig2-1941738118789954){ref-type="fig"}).^[@bibr7-1941738118789954],[@bibr55-1941738118789954],[@bibr67-1941738118789954],[@bibr83-1941738118789954],[@bibr99-1941738118789954],[@bibr104-1941738118789954]^ Systemic symptoms are much less common in recurrent HG, and symptoms typically last only 7 to 10 days. Treatment with oral antiviral medications can shorten the duration of illness by 2 to 5 days, allowing the athlete to return to play sooner.^[@bibr9-1941738118789954],[@bibr99-1941738118789954]^

![Recurrent herpes gladiatorum. Smaller area of involvement and fewer systemic symptoms.](10.1177_1941738118789954-fig2){#fig2-1941738118789954}

Microbiological testing for HSV-1 and -2 is strongly recommended because HG is commonly confused with other skin infections in wrestlers.^[@bibr6-1941738118789954],[@bibr67-1941738118789954],[@bibr99-1941738118789954]^ Up to 90% of HG infections are misdiagnosed by physicians at first presentation.^[@bibr35-1941738118789954]^ In addition, microbiological testing can help distinguish herpes gingivostomatitis and sycosis from other causes of pharyngitis and folliculitis.^[@bibr99-1941738118789954],[@bibr104-1941738118789954]^ Because of the high rates of seropositivity and low rates of active disease in seropositive individuals, serologic testing for HSV has limited clinical value. HSV seropositivity commonly lags behind clinical infection. A negative test does not rule out active HSV infection, and a positive test has a high likelihood of false-positivity when attempting to differentiate active disease. For these reasons, direct microbiologic testing of active lesions is preferred over serologic testing. Rarely, varicella zoster virus infection can be confused with primary HG, but it presents with a more pronounced prodrome of pruritus and hypersensitivity and forms along dermatomal patterns.^[@bibr49-1941738118789954],[@bibr71-1941738118789954]^

Viral culture and HSV polymerase chain reaction both have good sensitivity and near perfect specificity. Depending on the clinical context, either is a reasonable diagnostic test. Culture is much less expensive, but polymerase chain reaction generally provides more rapid results.^[@bibr47-1941738118789954],[@bibr93-1941738118789954],[@bibr99-1941738118789954]^ A Tzank smear is no longer favored due to poor sensitivity and specificity.^[@bibr47-1941738118789954],[@bibr99-1941738118789954]^ Fluid obtained from rupturing 5 to 7 vesicles is the best source for maximum viral content.^[@bibr7-1941738118789954]^ This fluid should be collected using a swab/media that does not contain alginate (which inhibits HSV growth) and has a plastic or metal shaft (wood may be toxic to HSV in culture).^[@bibr22-1941738118789954],[@bibr34-1941738118789954],[@bibr93-1941738118789954]^

Oral antiviral treatment should be initiated based on clinical suspicion, and all infected athletes should be withheld from contact with other athletes and equipment until the infection is cleared. Medication expedites the clearance of an outbreak but may take as long as 10 to 14 days. Treatment not only speeds resolution of symptoms in the infected athlete but also prevents transmission to an exposed opponent.^[@bibr9-1941738118789954],[@bibr55-1941738118789954],[@bibr104-1941738118789954]^

As with all HSV infections, prevention of HG transmission is difficult. Up to 87.4% of HSV outbreaks are subclinical and go unnoticed.^[@bibr22-1941738118789954]^ A large number of potentially infected but asymptomatic athletes can lead to large outbreaks at inopportune times, including during camps and postseason competition. Oral valacyclovir has been shown to decrease risk of HSV acquisition and prevent recurrence of previous HG.^[@bibr10-1941738118789954]^ A recent 10-year study of wrestlers at a 28-day wrestling camp demonstrated that daily oral valacyclovir decreased recurrent HG outbreaks by 89.5% and prevented contraction of the virus in HSV-naive wrestlers.^[@bibr10-1941738118789954]^ Overall, there is strong evidence that the use of oral valacyclovir dramatically decreases risk of both acquiring HSV and having an HG outbreak in both HSV-seropositive wrestlers and those that are HSV-naive.^[@bibr6-1941738118789954][@bibr7-1941738118789954][@bibr8-1941738118789954][@bibr9-1941738118789954]-[@bibr10-1941738118789954],[@bibr79-1941738118789954],[@bibr80-1941738118789954]^ For those considering anti-viral prophylaxis of HG, it is generally best to start the medication at least 5 days before the season, camp, or tournament begins to ensure adequate drug levels in the ganglia.^[@bibr10-1941738118789954]^ Complete recommendations for treatment and prophylaxis of HG are presented in [Table 2](#table2-1941738118789954){ref-type="table"}.

Tinea Corporis Gladiatorum {#section9-1941738118789954}
==========================

The dermatophyte *Trichophyton tonsurans* causes most of the fungal infections seen in cutaneous tissues and is responsible for 90% of tinea capitis.^[@bibr62-1941738118789954],[@bibr104-1941738118789954],[@bibr105-1941738118789954]^ Considered a nuisance infection, tinea corporis gladiatorum (TCG) or "ringworm" affects 60% of collegiate and 52% of high school wrestlers each season.^[@bibr104-1941738118789954][@bibr105-1941738118789954]-[@bibr106-1941738118789954]^ Multiple epidemics have been reported.^[@bibr13-1941738118789954],[@bibr29-1941738118789954],[@bibr37-1941738118789954],[@bibr39-1941738118789954],[@bibr43-1941738118789954],[@bibr53-1941738118789954],[@bibr85-1941738118789954]^

Ringworm spreads primarily via direct skin-to-skin contact with an infected individual. Colonized fomites (inanimate surfaces and equipment) may serve as a source of infection, but this is relatively rare.^[@bibr2-1941738118789954],[@bibr42-1941738118789954],[@bibr62-1941738118789954]^ Open sores and abrasions increase the risk of transmission.^[@bibr2-1941738118789954],[@bibr3-1941738118789954]^ Symptoms typically appear 3 to 5 days after exposure and start as a small red spot that grows and progresses to an annular lesion up to 5 to 8 cm in diameter ([Figure 3](#fig3-1941738118789954){ref-type="fig"}). The peripheral border is usually slightly reddened and flaky. The central area may be clear but have a slight red to brown coloration. The scalp, face, upper thorax, and upper extremities are most commonly affected.^[@bibr2-1941738118789954]^

![Tinea corporis gladiatorum. Note the circular perimeter with flakiness and central clearing.](10.1177_1941738118789954-fig3){#fig3-1941738118789954}

It is likely that asymptomatic wrestlers act as a reservoir for the pathogen.^[@bibr2-1941738118789954],[@bibr3-1941738118789954],[@bibr51-1941738118789954],[@bibr85-1941738118789954]^ Notably, asymptomatic transmission has been documented in sumo wrestlers, where the scalp served as the reservoir.^[@bibr62-1941738118789954]^ This is likely common in other types of wrestling as well but has not been rigorously studied. Tinea is common on the scalp due to the predilection of the dermatophyte to its lipid-rich tissue. Deeper seeded scalp infections can occur and are usually associated with granulomatous formation, alopecia, and kerion formation ([Figure 4](#fig4-1941738118789954){ref-type="fig"}). Pustular drainage is common and, if left untreated, can lead to permanent hair loss.^[@bibr12-1941738118789954]^

![Kerion. Raised central area with purulent drainage. Also, hair loss over the central area.](10.1177_1941738118789954-fig4){#fig4-1941738118789954}

Diagnosis of TCG is usually clinical but sometimes can be difficult. Experience, suspicion, and knowing the athlete's history are all important factors that the clinician or certified athletic trainer must use to help accurately diagnose TCG. Application of potassium hydroxide (KOH) 10% solution to a scraping of the lesion will dissolve human cells, allow hyphae to be visible under low-power microscopy, and confirm the diagnosis. KOH-prepared skin scrapings are highly sensitive and specific when performed correctly.^[@bibr62-1941738118789954]^ However, many experienced wrestlers will start using topical antifungal creams prior to the lesion's being scraped for analysis, which may lead to false-negative KOH testing. In these situations, fungal culture can be useful. For skin lesions, a scraping of the skin generally provides sufficient sample for culture. For scalp lesions, several hair follicles should be removed for KOH testing on their roots. If negative for hyphae, additional fungal culture on the hair follicle roots may improve diagnostic yield. Fungal culture can take up to 3 weeks before results are available, so presumptive treatment with empiric topical (skin) or oral (hair) antifungal agents is advisable.

Treatment focuses on a balance of infection control, risk of transmission, and the interests of the athletes. Previous studies have demonstrated that it takes as many as 21 days of oral antifungal medication to eradicate a superficial tinea outbreak,^[@bibr18-1941738118789954]^ and kerion could take much longer. However, keeping a wrestler out for much of the competitive season to treat a nuisance infection seems unreasonable. NCAA and NHFS treatment guidelines (see [Table 1](#table1-1941738118789954){ref-type="table"}) focus on a balance for the athlete to return to competition versus the need to treat long enough to eradicate the fungus. It should be noted that all systemic antifungal medications carry a risk for substantial side effects. It is prudent to monitor for hepatotoxicity and/or bone marrow failure during treatment.^[@bibr63-1941738118789954]^

Preventative measures focus on proper hygiene and daily skin checks to keep fungal infections under control. However, recurrent TCG sometimes may develop when no visible source is found. For individuals with recurrent outbreaks, preventative treatment with oral antifungal medications has been shown to help reduce recurrent infections.^[@bibr18-1941738118789954],[@bibr48-1941738118789954],[@bibr64-1941738118789954]^ Ketoconazole 2% shampoo may help decrease transmission, but this has not been rigorously studied. Topical skin barriers have been purported to decrease TCG infections in wrestlers. However, there are no data on their effectiveness, and 1 study found that daily skin checks were as effective as topical skin barriers.^[@bibr48-1941738118789954]^ It is common for TCG infections to become a bigger issue toward the end of the competitive season during postseason tournament competition. Some wrestlers may seek prophylactic treatment with oral antifungal medications despite the known hepatotoxicity issues.

Molluscum Contagiosum {#section10-1941738118789954}
=====================

Considered a nuisance viral infection from the *Poxviridae* family, molluscum contagiosum appears as a small papule 2 to 10 mm in diameter, usually with no surrounding erythema and no regional adenopathy.^[@bibr86-1941738118789954],[@bibr101-1941738118789954],[@bibr106-1941738118789954]^ A small dimple appears on the top of its domed surface early in the course of the infection ([Figure 5](#fig5-1941738118789954){ref-type="fig"}). Rupturing the papule produces a caseous material with high viral content. This material is the vector for spread of the rash or transmission to other susceptible individuals. Molluscum contagiosum tends to appear in clusters of individuals with frequent close physical contact. Athletes in contact sports tend to contract lesions on areas of exposed skin, and sexually active individuals tend to contract them in the genital regions.^[@bibr31-1941738118789954],[@bibr101-1941738118789954]^ The infection can spread rapidly and often presents as several dozen lesions at initial diagnosis.

![Molluscum contagiosum. Two- to 10-mm-diameter dome-shaped lesions with a slight dimple on the surface with no surrounding erythema.](10.1177_1941738118789954-fig5){#fig5-1941738118789954}

Treatment focuses on removal of the lesion and prevention of further spread to susceptible competitors. The infection can be definitively treated by either curetting the lesions or by expressing the material and lightly burning the base of each papule with a hyfrecator. After removal of the lesions, athletes can immediately return to play with the treated sites covered by a bio-occlusive dressing.^[@bibr101-1941738118789954]^ Cryotherapy can be considered as an alternative treatment, although it takes much longer and is just as painful.^[@bibr101-1941738118789954]^

Verruca Vulgaris {#section11-1941738118789954}
================

Verruca vulgaris, the common wart, is a cutaneous infection by one of the human papillomaviruses. Warts present as scaly nodules and can appear anywhere on the body, although the hands and feet are most commonly affected. Warts are typically painless but can become painful if there is sufficient local trauma or abrasion to the region. Many treatments are effective, including topical acid preparations, cantharidin, podophyllin, tretinoin, duct tape, cryotherapy, and curettage. For most athletes, curettage and covering of the lesion is the preferred treatment because of the speed and simplicity of the method.^[@bibr33-1941738118789954],[@bibr86-1941738118789954],[@bibr104-1941738118789954]^

Scabies And Head Lice {#section12-1941738118789954}
=====================

Pediculosis (head, body, and pubic hair lice) and scabies are caused by ectoparasites. These infestations are easy to treat but sometimes difficult to diagnose. They are easily transmitted by direct skin-to-skin contact, but symptoms may not arise for 3 to 4 weeks, making early detection and treatment challenging.^[@bibr105-1941738118789954]^

The most common presenting symptom of lice is pruritus in hair-covered parts of the body.^[@bibr41-1941738118789954]^ Diagnosis requires visualization of living lice or viable nits (unhatched eggs). The presence of nit shells alone indicates a recent history of infestation but does not confirm active disease. Medicated shampoo with permethrin, phenothrin, or carbaryl is an effective treatment measure.^[@bibr41-1941738118789954],[@bibr56-1941738118789954]^

Scabies presents with a pruritic, papular rash that may include vesicles, pustules, or nodules.^[@bibr41-1941738118789954]^ These lesions are often found in the interdigital webspaces of the fingers and toes, but the most reliable dermatologic sign of scabies infestation is the presence of burrowing tracks in the skin. However, this finding is often absent. Definitive diagnosis can be made by viewing larvae in skin scrapings under low-power microscopy. The treatment of choice is topical permethrin cream.^[@bibr104-1941738118789954],[@bibr105-1941738118789954]^

In addition to eradication of the infestation on the athlete, cleaning of bedding, towels, and other infested fomites is also important. These materials should be washed in hot water with regular laundry detergent to decrease the risk of reinfestation. The Centers for Disease Control and Prevention recommends using a water temperature over 122°F. This temperature is sometimes unattainable in home washing machines, so commercial laundromats can be necessary to eradicate the infestation from certain fomites.^[@bibr25-1941738118789954]^

Conjunctivitis {#section13-1941738118789954}
==============

Viral and bacterial infections of the conjunctiva are common in athletes and nonathletes alike. Fortunately, most of these infections are benign and self-limited; however, they can be very easily transmitted between contact sport athletes. In a single large outbreak of *Streptococcus pneumoniae* conjunctivitis on a college campus, athletes were at higher risk of contracting the infection than nonathletes.^[@bibr72-1941738118789954]^ However, methods of controlling such outbreaks are controversial and poorly studied. The NCAA does not require treatment or demonstration of resolution prior to practice or competition. Topical ophthalmic antibiotics shorten duration of illness for bacterial conjunctivitis and may reduce transmission.^[@bibr54-1941738118789954],[@bibr94-1941738118789954]^

Human Immunodeficiency Virus {#section14-1941738118789954}
============================

Human immunodeficiency virus (HIV) is a rare blood-borne viral pathogen that causes a life-threatening syndrome called acquired immunodeficiency syndrome or AIDS. There has been 1 reported case of HIV transmission in contact sports.^[@bibr98-1941738118789954]^ The risk of HIV transmission in American football has been estimated at less than 1 in 85 million game contacts^[@bibr19-1941738118789954]^; however, this model was completed before the wide availability of effective antiretroviral agents and has not been replicated in other sports.

The risk of HIV exposure in contact sports is very low, but use of universal blood-borne pathogen precautions is still important. Bleeding wounds should be covered. Blood on uniforms, mats, or other fomites should be cleaned with soap and water, bleach, hydrogen peroxide, or other agents with antiviral properties. Health care workers should wear gloves whenever making contact with bodily fluids. The NCAA does not restrict sport participation for athletes with HIV.^[@bibr79-1941738118789954]^

Hepatitis B and C Viruses {#section15-1941738118789954}
=========================

Hepatitis C virus (HCV) is a viral pathogen that can cause life-threatening liver disease. There have been no documented cases of HCV transmission from athletic contact. Estimated risk of transmission in wrestling is very low,^[@bibr66-1941738118789954]^ but it has been reported that athletes in contact sports may be at increased risk of acquiring the infection.^[@bibr59-1941738118789954]^ Interestingly, 1 survey suggested that athletes who use injectable drugs are at very high risk of acquiring the infection.^[@bibr82-1941738118789954]^

Similarly, hepatitis B virus (HBV) is a blood-borne viral pathogen that can cause life-threatening liver disease. However, it is much more transmissible than HIV or HCV. Because of the higher concentration of this virus in the blood and better stability on environmental surfaces, risk of transmission of HBV has been estimated to be 50 to 100 times greater than transmission of HIV.^[@bibr66-1941738118789954],[@bibr73-1941738118789954]^ In health care workers, the risk of transmission after percutaneous exposure is 0.2% to 0.5% for HIV, 1.8% to 10% for HCV, and 2% to 40% for HBV.^[@bibr15-1941738118789954],[@bibr46-1941738118789954]^ Unlike HIV and HCV, there have been several reports of HBV transmission in sport.^[@bibr60-1941738118789954],[@bibr73-1941738118789954],[@bibr88-1941738118789954],[@bibr97-1941738118789954]^

Much like HIV, prevention of HCV infection is best achieved through use of universal blood-borne pathogen precautions, and athletes with HCV are not restricted from sport participation by any major governing body or association.^[@bibr80-1941738118789954],[@bibr82-1941738118789954]^

HBV is a vaccine-preventable illness. Universal precautions are important to prevent the spread of the virus to susceptible individuals, but high rates of vaccination and resultant herd immunity have made HBV infection increasingly uncommon.^[@bibr100-1941738118789954]^

Vaccine-Preventable Illnesses {#section16-1941738118789954}
=============================

The close physical contact experienced by athletes may increase their risk of acquiring vaccine-preventable illnesses. While no studies have evaluated vaccination status and risk of outbreaks of measles or mumps in athletes, there is some evidence to suggest that improved yearly influenza vaccine uptake decreases the number of influenza cases in a football team.^[@bibr84-1941738118789954]^ There have also been several outbreaks of measles and mumps associated with contact sport participation or attendance at sporting events.^[@bibr24-1941738118789954],[@bibr27-1941738118789954],[@bibr36-1941738118789954]^ In general, high rates of vaccination and the resultant herd immunity are very effective for preventing these serious infections, and encouraging vaccination among people who have close contact with others is an effective public health measure.

Body Grooming and Infection {#section17-1941738118789954}
===========================

Shaving, clipping, and waxing pubic hair has been associated with increased risk of sexually transmitted infections.^[@bibr30-1941738118789954],[@bibr31-1941738118789954],[@bibr81-1941738118789954]^ Anecdotally, such practices are common among young athletes. However, no studies have evaluated the effects of body grooming on infection risk in athletes.

Distinguishing Common Benign Skin Lesions From Infections {#section18-1941738118789954}
=========================================================

It is sometimes difficult to distinguish between skin infections and other dermatologic conditions. Eczema, psoriasis, and abrasions are common in athletes and should not be confused with skin infections. Other, less common skin conditions, such as hidradenitis suppurativa, may also mimic skin infections. Athletes with such noninfectious skin lesions may be at increased risk for secondary infections. When there is uncertainty regarding the cause of a skin lesion, culture or biopsy can help differentiate infection from these benign conditions. It is often prudent to treat for suspected infections while awaiting results of confirmatory testing. Open skin wounds should be covered during practice and competition but do not preclude sport participation.

Conclusion {#section19-1941738118789954}
==========

Infectious diseases, especially infections of the skin, are common in contact sport athletes. Close monitoring and high levels of suspicion are important for early diagnosis. Infection control is achieved primarily through early and aggressive treatment and by removal of infected athletes from play until they are no longer contagious. Most infections are transmitted through direct human-to-human contact. Mats and other fomites serve as only minor vectors.
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